Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PLATELET FACTOR 4' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 227 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Connell, RD; Beebe, JS
      Patent focus on cancer chemotherapeutics. III Angiogenesis agents: October2000-March 2001

      EXPERT OPINION ON THERAPEUTIC PATENTS
    2. Gerotziafas, GT; Elalamy, I; Lecrubier, C; Lebrazi, J; Mirshahi, M; Potevin, F; Lecompte, T; Samama, MM
      The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia

      BLOOD COAGULATION & FIBRINOLYSIS
    3. Foss, B; Ulvestad, E; Bruserud, O
      Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia:PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts

      EUROPEAN JOURNAL OF HAEMATOLOGY
    4. Morita, S; Gebska, MA; Kakkar, AK; Scully, MF
      High affinity binding of heparin by necrotic tumour cells neutralises anticoagulant activity - Implications for cancer related thromboembolism and heparin therapy

      THROMBOSIS AND HAEMOSTASIS
    5. Farner, B; Eichler, P; Kroll, H; Greinacher, A
      A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia

      THROMBOSIS AND HAEMOSTASIS
    6. Griffioen, AW; van der Schaft, DWJ; Barendsz-Janson, AF; Cox, A; Boudier, HAJS; Hillen, HFP; Mayo, KH
      Anginex, a designed peptide that inhibits angiogenesis

      BIOCHEMICAL JOURNAL
    7. Bacsi, S; Geoffrey, R; Visentin, G; De Palma, R; Aster, R; Gorski, J
      Identification of T cells responding to a self-protein modified by an external agent

      HUMAN IMMUNOLOGY
    8. Panasiuk, A; Prokopowicz, D; Zak, J; Matowicka-Karna, J; Osada, J; Wysocka, J
      Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4

      HEPATO-GASTROENTEROLOGY
    9. Palestro, CJ; Weiland, FL; Seabold, JE; Valdivia, S; Tomas, MB; Moyer, BR; Baran, YM; Lister-James, J; Dean, RT
      Localizing infection with a technetium-99m-labeled peptide: initial results

      NUCLEAR MEDICINE COMMUNICATIONS
    10. Kaiser, P; Harenberg, J; Walenga, JM; Huhle, G; Giese, C; Prechel, M; Hoppensteadt, D; Fareed, J
      Effects of a heparin-binding protein on blood coagulation and platelet function

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    11. Warkentin, TE; Kelton, JG
      Temporal aspects of heparin-induced thrombocytopenia

      NEW ENGLAND JOURNAL OF MEDICINE
    12. Koster, A; Loebe, M; Sodian, R; Potapov, EV; Hansen, R; Muller, J; Mertzlufft, F; Crystal, GJ; Kuppe, H; Hetzer, R
      Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devices

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    13. Visentin, GP; Moghaddam, M; Beery, SE; McFarland, JG; Aster, RH
      Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    14. Guan, E; Wang, JH; Norcross, MA
      Identification of human macrophage inflammatory proteins 1 alpha and 1 beta as a native secreted heterodimer

      JOURNAL OF BIOLOGICAL CHEMISTRY
    15. Reilly, MP; Taylor, SM; Hartman, NK; Arepally, GM; Sachais, BS; Cines, DB; Poncz, M; McKenzie, SE
      Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through Fc gamma RIIA

      BLOOD
    16. Zhang, CY; Thornton, MA; Kowalska, MA; Sachis, BS; Feldman, M; Poncz, M; McKenzie, SE; Reilly, MP
      Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus

      BLOOD
    17. Konkle, BA; Bauer, TL; Arepally, G; Cines, DB; Poncz, M; McNulty, S; Edie, RN; Mannion, JD
      Heparin-induced thrombocytopenia: Bovine versus porcine heparin in cardiopulmonary bypass surgery

      ANNALS OF THORACIC SURGERY
    18. Zwischenberger, JB; Tao, W; Deyo, DJ; Vertrees, RA; Alpard, SK; Shulman, G
      Safety and efficacy of a heparin removal device: A prospective randomized preclinical outcomes study

      ANNALS OF THORACIC SURGERY
    19. Ashfield, JT; Meyers, T; Lowne, D; Varley, PG; Arnold, JRP; Tan, P; Yang, JC; Czaplewski, LG; Dudgeon, T; Fisher, J
      Chemical modification of a variant of human MIP-1 alpha; implications for dimer structure

      PROTEIN SCIENCE
    20. Korovesis, S; Fredericks, S; Holt, D; Toutouzas, P; Kaski, JC; Webb-Peploe, MM; Katritsis, D
      Release of platelet activation markers during coronary angioplasty

      CORONARY ARTERY DISEASE
    21. Theuerkauf, I; Lickfett, L; Harbrecht, U; Pohl, C; Fischer, HP; Pfeifer, U
      Segmental hepatic vein thrombosis associated with heparin-induced thrombocytopenia II

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    22. Neuhaus, TJ; Goetschel, P; Schmugge, M; Leumann, E
      Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid

      PEDIATRIC NEPHROLOGY
    23. Januzzi, JL; Jang, IK
      Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    24. Gruel, Y
      Antiphospholipid syndrome and heparin-induced thrombocytopenia: Update on similarities and differences

      JOURNAL OF AUTOIMMUNITY
    25. Brandt, E; Petersen, F; Ludwig, A; Ehlert, JE; Bock, L; Flad, HD
      The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation

      JOURNAL OF LEUKOCYTE BIOLOGY
    26. Miyashita, T; Nakajima, T; Hayashi, Y; Kuro, M
      Hemostatic effects of low-dose protamine following cardiopulmonary bypass

      AMERICAN JOURNAL OF HEMATOLOGY
    27. Jegger, D; Tevaearai, HT; Horisberger, J; Mueller, XM; Seigneuil, I; Pierrel, N; Boone, Y; von Segesser, LK
      Assembly of the Heparin Removal Device for patients with suspected adversereaction to protamine sulphate

      PERFUSION-UK
    28. Kawahito, K; Adachi, H; Ino, T
      Platelet activation in the Gyro C1E3 centrifugal pump: Comparison with theTerumo Capiox and the Nikkiso HPM-15

      ARTIFICIAL ORGANS
    29. Mazanet, MM; Neote, K; Hughes, CCW
      Expression of IFN-inducible T cell alpha chemoattractant by human endothelial cells is cyclosporin A-resistant and promotes T cell adhesion: Implications for cyclosporin A-resistant immune inflammation

      JOURNAL OF IMMUNOLOGY
    30. Vrij, AA; Rijken, J; van Wersch, JWJ; Stockbrugger, RW
      Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    31. Amiral, J; Pouplard, C; Vissac, AM; Walenga, JM; Jeske, W; Gruel, Y
      Affinity purification of heparin-dependent antibodies to platelet factor 4developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation

      BRITISH JOURNAL OF HAEMATOLOGY
    32. Bernardini, G; Spinetti, G; Ribatti, D; Camarda, G; Morbidelli, L; Ziche, M; Santoni, A; Capogrossi, MC; Napolitano, M
      I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo

      BLOOD
    33. Arepally, GM; Kamei, S; Park, KS; Kamei, K; Li, ZQ; Siegel, DL; Kisiel, W; Cines, DB; Poncz, M
      Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies

      BLOOD
    34. Fernandez, EJ; Wilken, J; Thompson, DA; Peiper, SC; Lolis, E
      Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation

      BIOCHEMISTRY
    35. Zaki, A; Salama, M; El Masry, M; Abou-Freikha, M; Abou-Ammo, D; Sweelum, M; Mashhour, E; Elhendy, A
      Immediate effect of balloon valvuloplasty on hemostatic changes in mitral stenosis

      AMERICAN JOURNAL OF CARDIOLOGY
    36. Elhakim, M; Fathy, A; Amine, H; Saeed, A; Mekawy, M
      Effect of i.v. tenoxicam during caesarean delivery on platelet activity

      ACTA ANAESTHESIOLOGICA SCANDINAVICA
    37. Weber, KSC; Nelson, PJ; Grone, HJ; Weber, C
      Expression of CCR2 by endothelial cells - Implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    38. Amiral, J; Vissac, AM
      Generation and pathogenicity of anti-platelet factor 4 antibodies: Diagnostic implications

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    39. Ahmad, S; Walenga, JM; Jeske, WP; Cella, G; Fareed, J
      Functional heterogeneity of antiheparin-platelet factor 4 antibodies: Implications in the pathogenesis of the HIT syndrome

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    40. Walenga, JM; Michal, K; Hoppensteadt, D; Wood, JJ; Robinson, JA; Bick, RL
      Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndrome

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    41. Despotis, GJ; Joist, JH
      Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: An update

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    42. Nicodemus, CF; Moyer, BR; Lister-James, J
      In vivo leukocytes labeling using a platelet factor 4-derived heparin binding peptide technetium complex

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    43. Flad, HD; Grage-Griebenow, E; Petersen, F; Scheuerer, B; Brandt, E; Baran, J; Pryjma, J; Ernst, M
      The role of cytokines in monocyte apoptosis

      PATHOBIOLOGY
    44. Sakiyama, SE; Schense, JC; Hubbell, JA
      Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering

      FASEB JOURNAL
    45. Oishi, M; Mochizuki, Y; Shikata, E
      Single lacunar brain infarction with transient signs versus those with long-lasting signs

      INTERNATIONAL ANGIOLOGY
    46. Bikfalvi, A
      Role of fibroblast growth factor-2 in tumor angiogenesis.

      PATHOLOGIE BIOLOGIE
    47. Visentin, GP
      Heparin-induced thrombocytopenia: Molecular pathogenesis

      THROMBOSIS AND HAEMOSTASIS
    48. Caen, JP; Han, ZC; Bellucci, S; Alemany, M
      Regulation of megakaryocytopoiesis

      HAEMOSTASIS
    49. Ornstein, DL; Zacharski, LR
      The use of heparin for treating human malignancies

      HAEMOSTASIS
    50. Kaplan, KL; Francis, CW
      Heparin-induced thrombocytopenia

      BLOOD REVIEWS
    51. Wallis, DE; Lewis, BE; Walenga, JM
      Failure of current strategies in the prevention of thrombosis in patients with heparin-induced thrombocytopenia: A clinician's perspective

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    52. Raible, MD
      Hematologic complications of heparin-induced thrombocytopenia

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    53. Walenga, JM; Jeske, WP; Fasanella, AR; Wood, JJ; Bakhos, M
      Laboratory tests for the diagnosis of heparin-induced thrombocytopenia

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    54. Aster, RH
      Drug-induced immune thrombocytopenia: An overview of pathogenesis

      SEMINARS IN HEMATOLOGY
    55. Oishi, M; Mochizuki, Y
      Cerebrovascular acetazolamide reactivity and platelet function in asymptomatic cerebral thrombosis

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    56. Byrnes, HD; Kaminski, H; Mirza, A; Deno, G; Lundell, D; Fine, JS
      Macrophage inflammatory protein-3 beta enhances IL-10 production by activated human peripheral blood monocytes and T cells

      JOURNAL OF IMMUNOLOGY
    57. Andjelkovic, AV; Spencer, DD; Pachter, JS
      Visualization of chemokine binding sites on human brain microvessels

      JOURNAL OF CELL BIOLOGY
    58. Carr, JA; Silverman, N
      The heparin-protamine interaction - A review

      JOURNAL OF CARDIOVASCULAR SURGERY
    59. Petersen, F; Brandt, E; Lindahl, U; Spillmann, D
      Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4

      JOURNAL OF BIOLOGICAL CHEMISTRY
    60. Griffioen, AW; Damen, CA; Mayo, KH; Barendsz-Janson, AF; Martinotti, S; Blijham, GH; Groenewegen, G
      Angiogenesis inhibitors overcome tumor induced endothelial cell anergy

      INTERNATIONAL JOURNAL OF CANCER
    61. Wang, LC; Huhle, G; Malsch, R; Hoffmann, V; Song, XLH; Harenberg, J
      Determination of heparin-induced IgG antibody in heparin-induced thrombocytopenia type II

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    62. Wallis, DE; Quintos, R; Wehrmacher, W; Messmore, H
      Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia

      CHEST
    63. Greinacher, A; Volpel, H; Janssens, U; Hach-Wunderle, V; Kemkes-Matthes, B; Eichler, P; Mueller-Velten, HG; Potzsch, B
      Recombinant hirudin (Lepirndin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia - A prospective study

      CIRCULATION
    64. Newman, PM; Chong, BH
      Further characterization of antibody and antigen in heparin-induced thrombocytopenia

      BRITISH JOURNAL OF HAEMATOLOGY
    65. Heinzelmann, M; Miller, M; Platz, A; Gordon, LE; Herzig, DO; Polk, HC
      Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes

      ANNALS OF SURGERY
    66. Despotis, GJ; Gravlee, G; Filos, K; Levy, J
      Anticoagulation monitoring during cardiac surgery - A review of current and emerging techniques

      ANESTHESIOLOGY
    67. Pouplard, C; Amiral, J; Borg, JY; Laporte-Simitsidis, S; Delahousse, B; Gruel, Y
      Decision analysis for use of platelet aggregation test, carbon 14 serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia

      AJCP. American journal of clinical pathology
    68. BAATOUT S
      PHORBOL ESTERS - USEFUL TOOLS TO STUDY MEGAKARYOCYTE DIFFERENTIATION

      HEMATOLOGY AND CELL THERAPY
    69. CARTER AM; CATTO AJ; BAMFORD JM; GRANT PJ
      PLATELET GP IIIA PIA AND GP IB VARIABLE NUMBER TANDEM REPEAT POLYMORPHISMS AND MARKERS OF PLATELET ACTIVATION IN ACUTE STROKE

      Arteriosclerosis, thrombosis, and vascular biology
    70. BROZENA SC; TWOMEY C; SIEGEL J; PETERSON P; HORROW JC; SAMUELS L; MORRIS R
      HEART-TRANSPLANTATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA ON THE NOVACOR LEFT-VENTRICULAR ASSIST SYSTEM

      The Journal of heart and lung transplantation
    71. SANTAMARIA A; ROMANI J; SOUTO JC; LOPEZ A; MATEO J; FONTCUBERTA J
      SKIN NECROSIS AT THE INJECTION SITE INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN - CASE-REPORT AND REVIEW

      Dermatology
    72. OLBRICH K; WIERSBITZKY M; WACKE W; EICHLER P; ZINKE H; SCHWOCK M; MOX B; KRAATZ G; MOTZ W; GREINACHER A
      ATYPICAL HEPARIN-INDUCED THROMBOCYTOPENIA COMPLICATED BY INTRACARDIACTHROMBUS, EFFECTIVELY TREATED WITH ULTRA-LOW-DOSE RT-PA LYSIS AND RECOMBINANT HIRUDIN (LEPIRUDIN)

      Blood coagulation & fibrinolysis
    73. Amiral, J; Meyer, D
      Heparin-induced thrombocytopenia: diagnostic tests and biological mechanisms

      BAILLIERES CLINICAL HAEMATOLOGY
    74. AIDOUDI S; GUIGON M; DROUET V; CAEN JP; HAN ZC
      THE TETRAPEPTIDE ACSDKP REDUCES THE SENSITIVITY OF MURINE CFU-MK AND CFU-GM PROGENITORS TO ARACYTINE IN-VITRO AND IN-VIVO

      International journal of hematology
    75. Buyukasik, Y; Soylu, B; Soylu, AR; Ozcebe, OI; Canbakan, S; Haznedaroglu, IC; Kirazli, S; Baser, Y; Dundar, SV
      In vivo platelet and T-lymphocyte activities during pulmonary tuberculosis

      EUROPEAN RESPIRATORY JOURNAL
    76. STEFANIDIS I; FRANK D; MAURIN N
      HEMOSTASIS ACTIVATION MARKERS IN ACUTE-RENAL-FAILURE

      Renal failure
    77. HEIDRICH H; KAHL K; PENNINGER C; BECHSTEIN B; BIRKENMAIER M; DRESSLER S; FAHRIG C; HELMIS J; HERMAN G; VONKNOBLOCH U; LADLEIF M; MEIER K; RUDOLPH M; SCHLICH B; WANKE M; ZWERNEMANN B
      HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIE NTS TREATED WITH UNFRACTIONATED HEPARIN - A PROSPECTIVE CLINICAL-TRIAL OF THE INCIDENCE IN PATIENTS WITH INTERNAL DISEASES IN-HOSPITAL

      Medizinische Klinik
    78. HORNE MK; HUTCHISON KJ
      SIMULTANEOUS BINDING OF HEPARIN AND PLATELET-FACTOR-4 TO PLATELETS - FURTHER INSIGHTS INTO THE MECHANISM OF HEPARIN-LNDUCED THROMBOCYTOPENIA

      American journal of hematology
    79. FERNANDEZ AO; FERNANDEZ AH; DOMINGUEZ JMB; TEJERO PG; BERNAL JP; HINOJOSA R; HIDALGO JL
      THE SYSTEMIC VASODILATORY ACTION OF PROTAMINE - IS IT INHIBITED OR MEDIATED BY HEPARIN

      Research in experimental medicine
    80. CELIK C; KONUKOGLU D; OZMEN M; AKCAY T
      PLATELET-SPECIFIC PROTEINS IN LITHIUM-CARBONATE TREATMENT

      Medical science research
    81. Borgstrom, P; Discipio, R; Maione, TE
      Recombinant platelet factor 4, an angiogenic marker for human breast carcinoma

      ANTICANCER RESEARCH
    82. Chihara, J; Yamada, H; Yamamoto, T; Kurachi, D; Hayashi-Kameda, N; Honda, K; Kayaba, H; Urayama, O
      Priming effect of RANTES on eosinophil oxidative metabolism

      ALLERGY
    83. HAUER KE
      LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS

      Western journal of medicine
    84. KOZEKLANGENECKER SA; KETTNER SC; OISMUELLER C; GONANO C; SPEISER W; ZIMPFER M
      ANTICOAGULATION WITH PROSTAGLANDIN E-1 AND UNFRACTIONATED HEPARIN DURING CONTINUOUS VENOVENOUS HEMOFILTRATION

      Critical care medicine
    85. Ortel, TL
      Heparin-induced thrombocytopenia

      SEMINARS IN HEMATOLOGY
    86. SCHEFFOLD N; MAITRA R; CYRAN J
      HEPARIN-INDUCED THROMBOCYTOPENIA

      Schweizerische medizinische Wochenschrift
    87. KELTON JG; WARKENTIN TE
      HEPARIN-INDUCED THROMBOCYTOPENIA - DIAGNOSIS, NATURAL-HISTORY, AND TREATMENT OPTIONS

      Postgraduate medicine
    88. LUSTER AD
      CHEMOKINES - CHEMOTACTIC CYTOKINES THAT MEDIATE INFLAMMATION

      The New England journal of medicine
    89. KAWABATA K; NAGAKE Y; SHIKATA K; FUKUDA S; NAKAZONO H; TAKAHASHI M; ICHIKAWA H; MAKINO H
      SOLUBLE P-SELECTIN IS RELEASED FROM ACTIVATED PLATELETS IN-VIVO DURING HEMODIALYSIS

      Nephron
    90. GERSHENGORN MC; GERASRAAKA E; VARMA A; CLARKLEWIS I
      CHEMOKINES ACTIVATE KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS G-PROTEIN-COUPLED RECEPTOR IN MAMMALIAN-CELLS IN CULTURE

      The Journal of clinical investigation
    91. PRESTA M; BELLERI M; VECCHI A; HESSELGESSER J; MANTOVANI A; HORUK R
      NONCOMPETITIVE, CHEMOKINE-MEDIATED INHIBITION OF BASIC FIBROBLAST GROWTH FACTOR-INDUCED ENDOTHELIAL-CELL PROLIFERATION

      The Journal of biological chemistry
    92. BROIJERSEN A; KARPE F; HAMSTEN A; GOODALL AH; HJEMDAHL P
      ALIMENTARY LIPEMIA ENHANCES THE MEMBRANE EXPRESSION OF PLATELET P-SELECTIN WITHOUT AFFECTING OTHER MARKERS OF PLATELET ACTIVATION

      Atherosclerosis
    93. Oishi, M; Mochizuki, Y
      beta-thromboglobulin and 11-dehydrothromboxane B-2 in tension-type headache

      HEADACHE
    94. Minami, T; Tachibana, K; Imanishi, T; Doi, T
      Both Ets-1 and GATA-1 are essential for positive regulation of platelet factor 4 gene expression

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    95. HIRSH J
      LOW-MOLECULAR-WEIGHT HEPARIN - A REVIEW OF THE RESULTS OF RECENT STUDIES OF THE TREATMENT OF VENOUS THROMBOEMBOLISM AND UNSTABLE ANGINA

      Circulation
    96. TROSSAERT M; GAILLARD A; COMMIN PL; AMIRAL J; VISSAC AM
      HIGH-INCIDENCE OF ANTI-HEPARIN PLATELET FACTOR-4 ANTIBODIES AFTER CARDIOPULMONARY BYPASS-SURGERY/

      British Journal of Haematology
    97. CARLSSON LE; SANTOSO S; BAURICHTER G; KROLL H; PAPENBERG S; EICHLER P; WESTERDAAL NAC; KIEFEL V; VANDEWINKEL JGJ; GREINACHER A
      HEPARIN-INDUCED THROMBOCYTOPENIA - NEW INSIGHTS INTO THE IMPACT OF THE FC-GAMMA-RIIA-R-H131 POLYMORPHISM

      Blood
    98. REZAIE AR
      RAPID ACTIVATION OF PROTEIN-C BY FACTOR XA AND THROMBIN IN THE PRESENCE OF POLYANIONIC COMPOUNDS

      Blood
    99. LEWIS BE; RANGEL Y; FAREED J
      THE FIRST REPORT OF SUCCESSFUL CAROTID STENT IMPLANT USING ARGATROBANANTICOAGULATION IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS SYNDROME - A CASE-REPORT

      Angiology
    100. HIRSH J
      LOW-MOLECULAR-WEIGHT HEPARIN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM

      The American heart journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 21:20:05